Mortimore steps down as Merge CEO
After a dozen years at the helm of Merge Technologies, PACS and connectivity veteran Bill Mortimore has turned over the reins to Richard Linden. The move comes as part of a management restructuring that makes Linden president and CEO and Mortimore
After a dozen years at the helm of Merge Technologies, PACS and connectivity veteran Bill Mortimore has turned over the reins to Richard Linden. The move comes as part of a management restructuring that makes Linden president and CEO and Mortimore chairman and chief strategist.
In addition to founding Merge in 1987, Mortimore is one of the original members of the American College of Radiology/National Electrical Manufacturers Association (ACR/NEMA) committee responsible for establishing and maintaining the DICOM medical imaging standard. He also serves as chair of the Medical Imaging Informatics Section of NEMA and as a member of the board of directors of NEMAs diagnostic imaging division.
Under Mortimores leadership, Merge Technologies has moved from OEM-focused product distribution to a combination of OEM, value-added reseller, and direct sales. In addition, the firm has increased its core connectivity product portfolio (enabling the exchange of data in standard HL7 and DICOM formats between disparate legacy systems) to include Java-based text and image data exchange.
In his new position at Merge, Mortimore will turn his attention to advancing the strategic business and financial strategies of the Milwaukee-based firm, with particular emphasis on moving the company beyond its traditional clinical base into the broader healthcare environment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
